Soligenix
SNGX
#10276
Rank
HK$98.49 M
Marketcap
HK$9.77
Share price
-4.58%
Change (1 day)
-45.74%
Change (1 year)

EPS for Soligenix (SNGX)

EPS in 2025 (TTM): -HK$25.26

According to Soligenix's latest financial reports the company's current EPS (TTM) is -HK$25.31. In 2024 the company made an earnings per share (EPS) of -HK$38.91 an increase over its 2023 EPS that were of -HK$98.91.

EPS history for Soligenix from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$25.26-35.08%
2024-HK$38.91-60.66%
2023-HK$98.91-83.55%
2022-HK$601.2713.95%
2021-HK$527.64-56.03%
2020-HK$1,20033.33%
2019-HK$900.02-29.41%
2018-HK$1,275-41.38%
2017-HK$2,17524.73%
2016-HK$1,744-69%
2015-HK$5,625-6.25%
2014-HK$6,000-50.77%
2013-HK$12,18875.68%
2012-HK$6,93868.18%
2011-HK$4,125-69.86%
2010-HK$13,688-8.75%
2009-HK$15,00033.33%
2008-HK$11,250-57.14%
2007-HK$26,251-46.15%
2006-HK$48,75144.44%
2005-HK$33,751-40.7%
2004-HK$56,919-15.62%
2003-HK$67,459-25.52%
2002-HK$90,572-80.94%
2001-HK$475,179160.89%
2000-HK$182,136-40.57%
1999-HK$306,454-63.84%
1998-HK$847,522601.73%
1997-HK$120,776101.7%
1996-HK$59,880

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$81.56-422.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$13.44-153.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$28.95-214.37%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-HK$7.42-70.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-HK$15.86-37.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$4.92-119.44%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Emergent BioSolutions
EBS
HK$11.02-143.52%๐Ÿ‡บ๐Ÿ‡ธ USA